Larvol Delta - Safety-and-Tolerability-of-SRX246-a-Vasopressin-1a-Antagonist-in-Irritable-Huntington39s-Disease-PatientsA-Randomized-Phase-2-Clinical-Trial

SRX246 - Azevan

http://www.ncbi.nlm.nih.gov/pubmed/33207828

Nov 21, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next